Cargando…

Pathway-Driven Discovery of Rare Mutational Impact on Cancer

Identifying driver mutation is important in understanding disease mechanism and future application of custom tailored therapeutic decision. Functional analysis of mutational impact usually focuses on the gene expression level of the mutated gene itself. However, complex regulatory network may cause...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, TaeJin, Park, Taesung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026869/ https://www.ncbi.nlm.nih.gov/pubmed/24883302 http://dx.doi.org/10.1155/2014/171892

Ejemplares similares

Personalized identification of altered pathways in cancer using accumulated normal tissue data
por: Ahn, TaeJin, et al.
Publicado: (2014)

Ovarian Cancer Prognostic Prediction Model Using RNA Sequencing Data
por: Jeong, Seokho, et al.
Publicado: (2018)

Pathway-Driven Approaches of Interaction between Oxidative Balance and Genetic Polymorphism on Metabolic Syndrome
por: Lee, Ho-Sun, et al.
Publicado: (2017)

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
por: Yenerall, Paul, et al.
Publicado: (2021)

Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer
por: Park, Yeon Hee, et al.
Publicado: (2015)

Classification and Functional Analysis between Cancer and Normal Tissues Using Explainable Pathway Deep Learning through RNA-Sequencing Gene Expression
por: Park, Sangick, et al.
Publicado: (2021)

Patient-driven initiatives for prioritizing drug discovery for rare diseases
por: Bhattacharya, Alok, et al.
Publicado: (2019)

Pathway-based approach using hierarchical components of rare variants to analyze multiple phenotypes
por: Lee, Sungyoung, et al.
Publicado: (2018)

Storing Digital Information in Long-Read DNA
por: Ahn, TaeJin, et al.
Publicado: (2018)

CANcer-specific Evaluation System (CANES): a high-accuracy platform, for preclinical single/multi-biomarker discovery
por: Kwon, Min-Seok, et al.
Publicado: (2017)

Pathway analysis of rare variants for the clustered phenotypes by using hierarchical structured components analysis
por: Lee, Sungyoung, et al.
Publicado: (2019)

Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells
por: Yadavalli, S., et al.
Publicado: (2017)

Pathway-Based Evaluation in Early Onset Colorectal Cancer Suggests Focal Adhesion and Immunosuppression along with Epithelial-Mesenchymal Transition
por: Nam, Seungyoon, et al.
Publicado: (2012)

Deep Learning for Integrated Analysis of Insulin Resistance with Multi-Omics Data
por: Huang, Eunchong, et al.
Publicado: (2021)

What Should Be Considered for Local Excision in Early Rectal Cancer?
por: Ahn, Taesung
Publicado: (2019)

Discovery of rare mutations in extensively pooled DNA samples using multiple target enrichment
por: Chi, Xu, et al.
Publicado: (2014)

Evaporation-driven transport-control of small molecules along nanoslits
por: Seo, Sangjin, et al.
Publicado: (2021)

Data-driven discovery of partial differential equations
por: Rudy, Samuel H., et al.
Publicado: (2017)

Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer
por: Huang, Shujun, et al.
Publicado: (2022)

Meta-Qtest: meta-analysis of quadratic test for rare variants
por: Ka, Jieun, et al.
Publicado: (2019)

Analysis of population-specific pharmacogenomic variants using next-generation sequencing data
por: Ahn, Eunyong, et al.
Publicado: (2017)

A Comparison of Methods for Data-Driven Cancer Outlier Discovery, and An Application Scheme to Semisupervised Predictive Biomarker Discovery
por: Karrila, Seppo, et al.
Publicado: (2011)

Nuclear receptor and VEGF pathways for gene-blood lead interactions, on bone mineral density, in Korean smokers
por: Lee, Ho-Sun, et al.
Publicado: (2018)

Data-Driven Discovery of Molecular Targets for Antibody-Drug Conjugates in Cancer Treatment
por: Razzaghdoust, Abolfazl, et al.
Publicado: (2021)

Targeting autophagic pathways for cancer drug discovery
por: Liu, Bo, et al.
Publicado: (2013)

An argument for discovery-driven research: from physicist to cancer researcher
por: Retsky, Michael
Publicado: (2014)

Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases
por: Park, Sungjin, et al.
Publicado: (2019)

GxGrare: gene-gene interaction analysis method for rare variants from high-throughput sequencing data
por: Kwon, Minseok, et al.
Publicado: (2018)

PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
por: Nisa, Lluís, et al.
Publicado: (2017)

Data driven discovery of cyber physical systems
por: Yuan, Ye, et al.
Publicado: (2019)

New Common and Rare Variants Influencing Metabolic Syndrome and Its Individual Components in a Korean Population
por: Lee, Ho-Sun, et al.
Publicado: (2018)

Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
por: Lee, Jiyun, et al.
Publicado: (2019)

Differentially mutated subnetworks discovery
por: Hajkarim, Morteza Chalabi, et al.
Publicado: (2019)

In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
por: Vanhauwaert, Suzanne, et al.
Publicado: (2018)

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer
por: Lee, Ji Yun, et al.
Publicado: (2015)

The impact of rare germline variants on human somatic mutation processes
por: Vali-Pour, Mischan, et al.
Publicado: (2022)

Deep Learning-driven research for drug discovery: Tackling Malaria
por: Neves, Bruno J., et al.
Publicado: (2020)

A new strategy for enhancing imputation quality of rare variants from next-generation sequencing data via combining SNP and exome chip data
por: Kim, Young Jin, et al.
Publicado: (2015)

Artificial-Neural-Network-Driven Innovations in Time-Varying Process Diagnosis of Low-K Oxide Deposition
por: Lee, Seunghwan, et al.
Publicado: (2023)

Data-Driven Discovery of Immune Contexture Biomarkers
por: Schwen, Lars Ole, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7r3fanqmmek40lr5vatriepbb5